type here...

CATEGORIES

For Doctors

LATEST

1...747576...104Page 75 of 104

TRENDING

EDITORS CHOICE

How OMICS and Other Predatory Publishers Enable Scientific Fraudsters

Robert Turner, Founding Editor -
Predatory Journals like OMICS and Pulsus pose a real danger to the scientific community and public alike.

Health Innovation Has a Friction Problem

Gil Bashe, Medika Life Editor -
The health care sector has entered one of the most innovative periods in modern history. Breakthrough medicines are transforming the care of obesity, diabetes,...

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

William Haseltine, PhD -
Advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories